ADIPOQ and metabolic disease: A large cross-sectional study reported a correlation between reduced adiponectin levels in early stages of diabetes or prediabetes and the severity of depression [50], that is, underlying metabolic disorders represent an initial confounding factor for adipokine-related studies.